🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, single arm, single center study to evaluate the effi...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-05-08
Trial ID
NCT05976997
Treatments Being Tested
This trial that is investigating a medication called duvelisib in combinati...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2021-10-14
Trial ID
NCT05057247
The researchers are doing this study to see if alectinib in combination wit...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (LimitedProtocol Activities)
Start Date
2025-08-08
Trial ID
NCT07001384
A Phase 3 (extension) clinical trial to examine the efficacy of IPI-145 (du...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02049515
Treatments Being Tested
This study will test the safety of ruxolitinib, given at one dose that does...
Status
Recruiting
Location
University of Miami (Data Collection Only)
Start Date
2021-08-12
Trial ID
NCT05010005
Treatments Being Tested
This phase II trial tests how well duvelisib works as treatment that is giv...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-10-01
Trial ID
NCT07293403
The purpose of this study is to examine the effects of multi-dose regimens ...
Status
Completed
Location
Investigational Site
Start Date
2012-07
Trial ID
NCT01653756
Treatments Being Tested
To evaluate the safety, pharmacokinetics, and pharmacodynamics of Duvelisib...
Status
Terminated
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02292225
Treatments Being Tested
To evaluate the effect of rifampin, a cytochrome P450 3A (CYP3A) inducer, o...
Status
Completed
Location
PRA International, Inc
Start Date
2013-10
Trial ID
NCT01947777
This phase Ib/II trial studies the side effects of acalabrutinib and duveli...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-07-01
Trial ID
NCT04836832
Treatments Being Tested